Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials. Archivio Italiano di Urologia e Andrologia, [S. l.], v. 96, n. 4, 2024. DOI: 10.4081/aiua.2024.12833. Disponível em: https://www.pagepressjournals.org/aiua/article/view/12833. Acesso em: 17 apr. 2026.